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Abstract
Background: Information on posttraumatic growth (PTG) among head and neck cancer (HNC)
survivors with a high level of distress is limited. The aim of this cross-sectional study was to investigate
the occurrence of PTG among distressed HNC survivors and its association with anxiety, depressive,
nicotine, and alcohol use disorders and health-related quality of life.
Methods: Seventy-four HNC survivors with psychological distress (Hospital Anxiety and Depression
Scale (HADS) anxiety> 7 and/or HADS depression> 7) completed the Posttraumatic Growth Inven-
tory, which comprises five subscales: relating to others, new possibilities, personal strength, spiritual
change, and appreciation of life, and the European Organization for Research and Treatment of Can-
cer Quality of Life Questionnaire. Anxiety, depressive, nicotine, and alcohol use disorders were mea-
sured using the Composite International Diagnostic Interview.
Results: Moderate to high Posttraumatic Growth Inventory (PTGI) scores occurred in 10% of the
HNC survivors with distress. The mean total PTGI score was 30.8 (SD= 19.7), with the highest mean
score on the subscale relating to others. A multivariate regression model consisting of tumor stage,
anxiety disorder, alcohol use disorder, and social functioning predicted total PTGI score best
(F(4, 64) = 7.565, p< .000, R2 = .321).
Conclusions: The presence of PTG in this population of distressed HNC survivors was low. PTG
occurred most in the domain of relating to others. Among distressed HNC survivors, higher PTG
was associated with lower tumor stage, absence of an anxiety disorder, absence of an alcohol use
disorder, and better social functioning.
Copyright © 2016 John Wiley & Sons, Ltd.
Background
It is increasingly acknowledged that adverse life events,
like cancer, can lead to the experience of positive psycho-
logical changes. Various terms are used for these changes,
such as posttraumatic growth (PTG) [1], benefit finding
[2], stress-related growth [3], and thriving [4]. Tedeschi
and Calhoun, who coined the term PTG, consider
these terms as roughly equivalent in meaning [5]. PTG is
defined as psychological growth beyond previous levels
of functioning, as a result of the struggle with a traumatic
event [5]. The subjective appraisal of a life-threatening
illness generates psychological distress, which activates a
coping process. Over time, this process may lead to PTG
in several areas of life: relating to others, new possibilities,
personal strength, spiritual change, and appreciation of
life.
Head and neck cancer (HNC) survivors often have to
deal with devastating consequences of this type of cancer
and its treatment, such as pain, fatigue, problems with
speech and swallowing, and changes in facial appearance.
These effects negatively affect their health-related quality
of life [6], and over 25% of HNC survivors suffer from
clinical levels of distress [7]. However, in this population,
moderate to high levels of PTG have consistently been
found [8–10], which are comparable to levels of PTG in
other cancer populations [11–13]. In a systematic review
including five studies, Harding and colleagues identified
several factors that seem to be associated with PTG in
HNC survivors: younger age at diagnosis, relationship sta-
tus, positive reframing, optimism, and hope [14].
Little is known, however, about the occurrence of PTG
specifically in HNC survivors with a high level of distress
and about the factors associated with it. Earlier studies in
HNC survivors did not find a significant association be-
tween PTG and distress [8,9,15]. According to Tedeschi
and Calhoun, distress and PTG can coexist. Some degree
of distress is needed to initiate the struggle resulting in
PTG, but PTG does not put an end to the distress caused
by cancer [5]. Possibly, PTG in distressed HNC survivors
may be moderate to high despite distress.
However, a meta-analysis on PTG in patients with can-
cer and HIV showed that there is great variability in effect
sizes between studies but that overall, there seems to be
Copyright © 2016 John Wiley & Sons, Ltd.
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a small relation between increased negative aspects of
mental health, including distress, and lower PTG [16].
A possible explanation for these inconclusive findings is
that the association between PTG and distress is nonlinear
but has an inverted U shape, because of three groups of
survivors [17]. One group of survivors may not have
perceived cancer as a severe or traumatizing illness, and
is less distressed, but therefore not engaged in coping
and PTG. Another group of survivors may experience
more distress, but may cope adequately, and therefore
experience higher levels of PTG. A third group may be
so heavily burdened by comorbid psychiatric symptoms,
such as anxiety and depression, that they experience
PTG to a limited extent. Because the details of PTG in dis-
tressed HNC survivors are unknown, the focus in this
study is specifically on PTG in this distressed survivor
group.
Among distressed HNC survivors, comorbid nicotine
and alcohol use disorders may be highly prevalent [18].
Nicotine and alcohol use can function as maladaptive
ways of coping with distress and may impede more
healthy coping processes, leading to PTG [19,20].
However, in two studies on HNC survivors, no associa-
tion between substance use and benefit finding was found
[8,9]. It is possible that substance use only hampers the
occurrence of PTG if it is substantial. Therefore, in
the current study, survivors with a nicotine and alcohol
use disorder were compared with survivors without these
diagnoses.
The aim of the present study was to investigate the
occurrence of PTG among HNC survivors with psycho-
logical distress and to examine the associations of PTG
with sociodemographic and clinical factors, nicotine and
alcohol use disorders, anxiety and depressive disorders,
and health-related quality of life. This study was designed
to contribute to a better understanding of PTG in HNC
survivors with psychological distress and to answer the
question whether it is a useful construct to address PTG
in psychological care for HNC survivors.
Methods
Participants
For this study, baseline data were used from a randomized
controlled trial on a stepped care intervention program
targeting psychological distress in HNC and lung cancer
survivors [21]. This study has been approved by the
Medical Ethical Committee of VU University Medical
Center, Amsterdam, The Netherlands. HNC survivors
were recruited between 2009 and 2013 at the Department
of Otolaryngology-Head and Neck Surgery of VU Univer-
sity Medical Center. All patients visiting the department
for follow-up consultation were screened for psychologi-
cal distress. Inclusion criteria were curative treatment for
HNC (squamous cell carcinoma of the lip, oral cavity,
oropharynx, hypopharynx, or larynx; all stages; all treat-
ment modalities), treatment completed at least 1 month
ago, and an increased level of psychological distress as
assessed by the Hospital Anxiety and Depression Scale
(HADS anxiety>7 and/or HADS depression>7). Exclu-
sion criteria were cognitive dysfunction, high suicide risk,
psychotic and/or manic signs, and too little knowledge of
the Dutch language to fill out the questionnaires. Because
the efficacy of stepped care was assessed in the interven-
tion study, current psychological treatment, or treatment
completed less than 2 months ago, were exclusion criteria,
as well. Eligible survivors who provided informed consent
had a diagnostic telephone interview (Composite Interna-
tional Diagnostic Interview (CIDI)) [22,23] and received
the baseline questionnaires. If the questionnaires were
not returned, participants received one telephonic
reminder.
Outcome measures
Participants completed questionnaires on PTG (Posttrau-
matic Growth Inventory (PTGI)), anxiety and depressive
symptoms (HADS), and health-related quality of life
(European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire-C30 (EORTC
QLQ-C30)). Anxiety and depressive disorders and nico-
tine and alcohol use disorders were measured using the
World Mental Health CIDI. Participants further filled out
a study specific questionnaire on sociodemographic fac-
tors: age, gender, relationship status, number of years of
education, and work situation. Illness-related information,
including tumor location, tumor stage, type of treatment,
and time since treatment, was obtained from medical
records.
The PTGI is a 21-item measure of posttraumatic
growth, validated in Dutch patients with cancer. It has five
subscales: relating to others, new possibilities, personal
strength, spiritual change, and appreciation of life.
A 6-point Likert scale was used with 0=not at all,
3 =moderate, and 5=very great degree of PTG. The total
score ranges from 0 to 105. A higher score indicates a
higher level of PTG [1,24]. To investigate the prevalence
of PTG, participants were divided in two groups. Mean
item scores of <3 were considered as low PTG and scores
of ≥3 as moderate to high PTG [25]. In the current study,
the PTGI had a Cronbach’s alpha of .92.
A validated Dutch version of the HADS was used to
assess psychological distress. The HADS is a 14-item
self-assessment scale for measuring distress with two
subscales: anxiety and depression. The total HADS score
ranges from 0 to 42, the subscales from 0 to 21. A HADS
anxiety or HADS depression score of >7 indicates an in-
creased risk for an anxiety or depressive disorder [26,27].
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Cronbach’s alphas were .77 for the HADS anxiety and .69
for the HADS depression subscale.
The 30-item EORTC QLQ-C30 includes a global
health-related quality of life scale and five functional
scales: physical functioning, role functioning, emotional
functioning, cognitive functioning, and social functioning.
There are three symptom scales: nausea and vomiting,
fatigue, and pain, and six single items. The single-item
scales were not used in this study. The scores of the
EORTC QLQ-C30 are linearly transformed to a scale of
0–100, with a higher score indicating a higher level of
functioning or global health-related quality of life or
a higher level of symptoms or problems [28,29].
Cronbach’s alphas of the subscales ranged from .66 to .92.
The CIDI (basic version 1.0, 12 months) is a compre-
hensive, fully structured diagnostic interview of the pres-
ence of mental disorders in the last 12 months according
to the criteria of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [22,23]. The disorders
assessed in the present study were depressive disorder,
anxiety disorder (generalized anxiety disorder, panic dis-
order, agoraphobia, social and specific phobia), nicotine
use disorder, and alcohol use disorder.
Statistical analyses
Descriptive statistics were used to describe the
sociodemographic and illness-related characteristics of
the study sample, the prevalence of PTG, and the scores
on the measurement instruments. Univariate analyses
were used to examine the association of PTG with
sociodemographic and illness-related variables, the
HADS, EORTC QLQ-C30, and CIDI diagnoses. Vari-
ables with p< .10 were tested for multicollinearity, using
variance inflation factors and tolerance statistics, and were
entered into a backward elimination regression analysis
with the PTGI total score as outcome variable. Based on
a power analysis, the number of determinants of the PTGI
total score in the multiple regression was limited to a
maximum of 7. In all analyses, a p< .05 was considered
statistically significant. IBM SPSS Statistics for Windows
version 21 was used to perform all tests.
Results
Participants
In total, 920 HNC survivors were screened, 162 (18%)
survivors met all inclusion criteria, and 84 (52%) of them
agreed to participate. Four participants (5%) could not be
reached during the study, and six (7%) returned question-
naires with >2 missing PTGI items and were excluded
from analyses. Survivors who declined participation did
not differ from participants in terms of gender and HADS
score, but they were on average older (M=65.0,
SD=10.6) than participants (M=61.2, SD=8.5) (t(148)
=2.413, p< .05). Participant characteristics of the
remaining 74 survivors are shown in Table 1. In summary,
their mean age was 61 years, 58% was male, and 37% was
working. They were on average 22 months after treatment,
and 50% had tumor stage III or IV at diagnosis. Twelve
percent had an anxiety disorder, 20% a depressive disor-
der, 23% a nicotine use disorder, and 14% was diagnosed
with an alcohol use disorder.
Posttraumatic growth
Descriptive statistics of the PTGI total scale and sub-
scales, the HADS, and EORTC QLQ-C30 are shown in
Table 2. The mean PTGI score was 30.8 (SD=19.7).
The majority (90%) scored low (mean item score <3)
on this scale, and a minority of 10% reported moderate
to high (mean item score ≥3) PTG. The highest growth
was reported on the subscale relating to others
(M=13.1, SD=7.7) and the lowest on spiritual change
(M=1.4, SD=2.2).
Univariate analyses of associations with PTG
Univariate analyses (Table 3) showed that females
had higher scores on the total PTGI scale than males
(t(48.4) =2.057, p< .05). Age, living situation, number
of years of education, and work situation were not signif-
icantly related to PTGI score.
Table 1. Sociodemographic and clinical characteristics of the study
population (n= 74)
Variable n % M SD Range
Age (years) 61.2 8.5 41–83
Gender (female) 31 41.9
Living situation (with partner) 52 70.3
Years of education 11.5 3.4 5–21
Employment (paid work) 27 36.5
Tumor location




I and II 33 44.6






Combination surgery and other 25 33.8
Months since treatment 22.4 25.8 1–99
CIDI diagnosis
Anxiety disorder (yes) 9 12.2
Depressive disorder (yes) 15 20.3
Nicotine use disorder (yes) 17 23.0
Alcohol use disorder (yes) 10 13.5
CIDI, Composite International Diagnostic Interview.
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Further, tumor stage was significantly associated with
PTGI score (t(51.0)= 2.490, p< .05). Survivors with tu-
mor stage I or II at diagnosis had a higher PTGI score than
survivors with tumor stage III or IV. Tumor location, type
of treatment, and time since treatment were not signifi-
cantly related to PTGI score.
A lower score on depression (HADS depression;
r=.331, p< .01) and better social functioning
(rs= .264, p< .05) were associated with higher PTGI
scores. Anxiety (HADS anxiety), other domains of
health-related quality of life, diagnoses of depressive and
anxiety disorders, and nicotine and alcohol use disorders
were not significantly related to PTGI score.
Multivariate analysis of associations with PTG
A maximum of seven variables with p< .10 were entered
into a backward elimination regression analysis with the
PTGI total score as outcome variable. These criteria were
met by gender, tumor stage, HADS depression, CIDI di-
agnosis anxiety disorder, CIDI diagnosis alcohol use dis-
order, role functioning, and social functioning. The
variance inflation factors and tolerance values indicated
that multicollinearity was not a concern. Lower tumor
stage, absence of an anxiety disorder, absence of an alco-
hol use disorder, and better social functioning were associ-
ated with a higher score on the PTGI (F(4, 64)=7.565,
p< .000, R2 = .321) (Table 4).
Discussion
This study was conducted to investigate the occurrence of
PTG and factors associated with PTG among HNC survi-
vors with psychological distress. Results showed that pos-
itive psychological changes do occur among distressed
HNC survivors, albeit to a relatively small extent. Among
these distressed HNC survivors, about 10% reported mod-
erate to high PTG. In contrast, in two other studies on
HNC survivors in general, 60–80% found a moderate to
high amount of benefits after cancer, measured with the
Benefit Finding Scale [8,9]. Also, in the present study,
the overall PTGI level was significantly lower (M=30.8,
SD=19.7) than, for example, in oral cavity cancer survi-
vors (M=51.8, SD=11.2, t(122)=6.793, p< .05) [10]
and in earlier studies on cancer survivors in general
[30,31]. An explanation may be that only patients with
Table 3. Univariate associations of sociodemographic, clinical, and
patient-reported outcomes with PTG
Variable Test statistic p Value R2
Age r =.013 .913 .000
Gender t(48.4) =2.057 .041* .065
Relationship status t(72) = 1.446 .153 .028
Years of education r =.097 .411 .009
Employment t(72) = .614 .541 .005
Tumor location F(2, 71) = 2.480 .091 .065
Tumor stage t(51.0) = 2.490 .016* .088
Type of treatment F(3, 70) = 1.159 .332 .047
Months since treatment rs=.187 .111 .026
HADS anxiety r = .014 .906 .000
HADS depression r =.331 .004** .109
EORTC QLQ-C30
Global quality of life r = .201 .087 .041
Physical functioning rs=.035 .768 .000
Role functioning rs=.207 .077 .029
Emotional functioning r = .056 .638 .003
Cognitive functioning rs=.011 .926 .006
Social functioning rs= .264 .024* .049
Fatigue rs=.149 .206 .013
Nausea vomiting rs= .020 .866 .002
Pain rs=.067 .573 .000
CIDI diagnosis
Depressive disorder t(72) = 1.019 .312 .014
Anxiety disorder t(72) = 1.862 .067 .046
Nicotine use disorder t(72) =0.446 .657 .003
Alcohol use disorder t(72) = 1.958 .054 .051
PTG, posttraumatic growth; HADS, Hospital Anxiety and Depression Scale; EORTC
QLQ-C30, European Organization for Research and Treatment of Cancer Quality of
Life Questionnaire-C30; CIDI, Composite International Diagnostic Interview.
*p< .05.
**p< .01.
Table 4. Regression model of PTG in HNC survivors with
psychological distress
Variable B SE B Bèta R2 p Value
Tumor stage -13.806 4.071 -0.355 .321 .001
Anxiety disorder (CIDI) -19.847 6.739 -0.309 .004
Alcohol use disorder -12.766 5.944 -0.221 .036
Social functioning 0.201 0.077 0.272 .011
PTG, posttraumatic growth; CIDI, Composite International Diagnostic Interview.
Table 2. Descriptive statistics on patient-reported outcomes
Measure M SD Range
PTGI 30.8 19.7 0–90
Relating to others 13.1 7.7 0–30
New possibilities 5.8 5.2 0–20
Personal strength 5.1 4.7 0–19
Spiritual change 1.4 2.2 0–9
Appreciation of life 5.5 4.1 0–15
HADS anxiety 9.6 3.8 0–18
HADS depression 9.1 3.6 0–19
EORTC QLQ-C30
Global quality of life 54.1 19.9 8–100
Physical functioning 69.7 20.5 13–100
Role functioning 60.6 26.5 0–100
Emotional functioning 52.0 25.8 0–100
Cognitive functioning 71.2 26.2 0–100
Social functioning 66.2 26.8 0–100
Fatigue 52.1 22.4 11–100
Nausea vomiting 10.8 17.8 0–100
Pain 38.7 29.5 0–100
n = 74 for all variables, except for global quality of life. For this variable n = 73.
PTGI, Posttraumatic Growth Inventory; HADS, Hospital Anxiety and Depression
Scale; EORTC QLQ-C30, European Organization for Research and Treatment of Can-
cer Quality of Life Questionnaire-C30.
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HNC with a high level of distress were included in this
study; survivors who do not perceive cancer as a severe
illness, and therefore have both lower distress and PTG
scores, were largely excluded. Distressed survivors may
be so heavily burdened by symptoms of anxiety or depres-
sion that they experience PTG only to a limited extent
[5,17]. These results suggest that distress and PTG can co-
exist but that higher levels of distress may inhibit coping
processes resulting in PTG.
In line with the idea that there is a relation between
perceived illness severity, distress and PTG, in the pres-
ent study, a higher tumor stage was associated with lower
PTG. An association between a higher tumor stage and
lower PTG was also reported by Ho and colleagues in
patients with oral cavity cancer [10]. Also, Tang and
colleagues found much lower PTG in terminally ill pa-
tients with cancer [32]. However, two other studies on
HNC survivors did not find this association [8,9]. In the
present study, lower PTG was also associated with the
presence of an anxiety disorder, which is in contrast with
earlier studies [33]. Further research is needed to explore
in more detail the associations between tumor stage,
perceived illness severity, distress, PTG, and anxiety
disorders.
With respect to coping style, it is interesting that in the
present study, lower PTG was associated with the pres-
ence of an alcohol use disorder. It may be that among
HNC survivors with psychological distress, for some alco-
hol abuse functions as a maladaptive coping style, while
PTG is the result of a more adaptive coping style for
others. This association was reported earlier in patients
with HIV [34] but was absent in previous studies on
patients with HNC [8,9]. Further, there is evidence that so-
cial support is positively associated with PTG in patients
with cancer [35]. The association between better social
functioning and higher PTG in the present study supports
these findings. Also, the fact that the highest PTG was
reported in the area of relations with others underscores
the importance of social relations for distressed HNC sur-
vivors. Perhaps, because HNC and its treatment can have
effects that severely impede social functioning, more lim-
itations in social functioning are associated with lower
PTG among HNC survivors.
Limitations of this study were that the sample size was
relatively small, all analyses were cross-sectional, which
precludes causal inference, and only 32% of the variance
in PTGI scores was explained. Several factors such as
coping style, perceived illness severity and life threat,
hope, and optimism were not assessed in this study but
could possibly explain an additional part of the variance
[11,13]. Further, a debate is ongoing about the interpreta-
tion of PTGI scores [36]. Tedeschi and Calhoun consider
these scores as reflecting genuine psychological growth
[5], while others suggest that PTG is a subjective percep-
tion of reality or a way of coping with a traumatic
experience, in which no real growth takes place. Further-
more, some studies suggest that PTG might be predictive
of negative psychological functioning [37]. It may be
that PTG functions as a coping style early after diagnosis
but becomes real growth after a longer period of time
[16]. Because the passage of time may impact PTG, it
is a limitation of the present study that the range in time
since treatment was large. Also, for this study, baseline
data were used from an intervention study. Distressed
survivors with a large suicide risk, or who already had
psychological treatment, were not included, which ham-
pers generalizability. Strengths of the present study were
that it specifically targeted HNC survivors with psycho-
logical distress and that, in addition to patient reported
anxiety and depressive symptoms, also depressive,
anxiety, nicotine, and alcohol use disorders were
investigated.
Prospective larger studies are needed to investigate the
development and course of PTG from diagnosis to long-
term follow-up in relation to possible moderators and me-
diators. Because in this study PTG occurred in only 10%
of distressed HNC survivors, intervention studies are
needed to investigate whether PTG can actually be stimu-
lated by psychological interventions for distressed cancer
survivors and whether that results in better psychological
functioning. Because in this study social functioning was
related to PTG, this may be particularly important to in-
corporate in such an intervention. However, experiencing
PTG should not be regarded as something that cancer sur-
vivors should necessarily accomplish but rather as a possi-
bility clinicians should be aware of and may facilitate
[38]. Based on the findings in the present study, PTG
could possibly be better facilitated if anxiety disorders
and alcohol use disorders are addressed, as well as social
functioning.
Conclusions
PTG occurred among HNC survivors with psychological
distress, albeit to a lesser extent compared with (HNC)
cancer survivors in general. A sense of improved relations
with others was the strongest domain of PTG. Among dis-
tressed HNC survivors, more PTG was experienced by
survivors with a lower tumor stage, no anxiety or alcohol
use disorder, and better social functioning.
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